Edgewise Therapeutics: Q4 Earnings Insights

Edgewise Therapeutics EWTX reported its Q4 earnings results on Thursday, February 22, 2024 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Edgewise Therapeutics missed estimated earnings by 9.3%, reporting an EPS of $-0.47 versus an estimate of $-0.43.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 3.67% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Edgewise Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.